Follow this preprint

Simulation model for productivity, risk and GDP impact forecasting of the COVID-19 portfolio vaccines

Vladimir Shnaydman
doi: https://doi.org/10.1101/2020.11.01.20214122
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.

Data Availability

Data is available

Back to top
Posted November 04, 2020.
Download PDF
Print/Save Options
Download PDFFull Text & In-line FiguresXML

Supplementary Material

Data/Code
Email
Simulation model for productivity, risk and GDP impact forecasting of the COVID-19 portfolio vaccines
Vladimir Shnaydman
medRxiv 2020.11.01.20214122; doi: https://doi.org/10.1101/2020.11.01.20214122
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area

Reviews and Context

0

Comment

0

TRIP Peer Reviews

0

Community Reviews

0

Automated Services

0

Blogs/Media

0

Author Videos

You can now receive automatic notifications when a preprint is revised, withdrawn, commented on, peer reviewed, or published in a journal. Select the events you would like to follow below and click "Submit". To see all of the preprints you are currently following, please go to the medRxiv Alerts Page.

Sign In to Follow this Preprint

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.